松龄血脉康胶囊辅助治疗原发性高血压效果及对患者生活质量影响.docVIP

松龄血脉康胶囊辅助治疗原发性高血压效果及对患者生活质量影响 　　[摘要] 目的 比较单用厄贝沙坦和联用松龄血脉康腔囊治疗原发性高血压的疗效及对患者生活质量的影响。 方法 选取2013年8月～2015年8月到我院就诊的236例原发性高血压患者为研究对象，随机分为对照组和联合用药组，各118例。对照组单用厄贝沙坦治疗，联合用药组加用松龄血脉康胶囊辅助治疗。两组患者用药1个月后血压稳定并达标者继续维持治疗3个月，比较两组患者的有效率及生活质量评分。 结果 治疗4个月后，两组的血压均较治疗前下降，联合用药组下降程度大于对照组；对照组和联合用药组血压总有效率分别为78.8%、92.4%，联合用药组疗效明显高于对照组（P0.05）；治疗后两组生活质量评分均较治疗前明显升高（P0.05）；联合用药组生活质量评分较对照组升高更为明显， 差异有统计学意义（P0.05）。 结论 使用松龄血脉康胶囊辅助厄贝沙坦治疗原发性高血压，取得较好的疗效，明显改善患者身体症状、情感状态、心理状况并能提高患者的生活满意度，对于提高患者的生活质量方面优于单用厄贝沙坦。 　　[关键词] 松龄血脉康胶囊；原发性高血压；厄贝沙坦片；生活质量 　　[中图分类号] R544.1 [文献标识码] A [文章编号] 1674-4721（2016）05（a）-0047-03 　　Effect of Songling Xuemaikang capsule as an adjuvant therapy on treating primary hypertension and its influence on patient′s quality of life 　　LI Yan-li 　　Department of Internal Medicine，Maternal and Child Health Hospital of Futian District in Shenzhen City，Shenzhen 518017，China 　　[Abstract] Objective To compare the effect of single-use of irbesartan and combination of Songling Xuemaikang capsule on treating primary hypertension and its influence on patient′s quality of life （QOL）. Methods From August 2013 to August 2015，236 patients with primary hypertension visited our hospital for treatments were selected as research objects.They were evenly divided into control group and combination group in random.In the control group，irbesartan was adopted，while in the combination group，Songling Xuemaikang capsule was added for an adjuvant therapy.Participants whose blood pressure were stable and met the standard after one-month medication were continued for another 3-month treatment.The effective rate and score of QOL were compared in both groups. Results After 4-month treatment，the blood pressure was decreased compared with before，and the degree of decrease in the combination group was greater than that of control group.The total effective rate in the control group and combination group was 78.8% and 92.4% respectively.The effect in the latter was much higher than that in the former （P 　　[Key words] Songl